We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mr
Prakash
Patel
02071887188
A-Star@gstt.nhs.uk
Prof
Carsten
Flohr
More information about this study, what is involved and how to take part can be found on the study website.
Atopic Eczema
This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.
Eczema (or dermatitis) is a dry skin condition that can affect people in different forms. It can lead to constant scratching, which causes the skin to split and bleed, and leaves it open to infection.
Eczema can be treated using “systemic immuno-modulators”. People with eczema have an overactive immune system that is inflamed. Immuno-modulators are used to suppress the immune system, which in turn reduces inflammation. As they are systemic, they affect the entire body, rather than just one specific area.
Since eczema is a long-term condition, it is important to understand how well such treatments work in terms of improvement in disease control, quality of life and safety over long periods of time. These treatments have undergone careful clinical trials, but the picture we get from clinical trials is not complete. This project aims to fill the gap in knowledge and collect information from patients using systemic immuno-modulators who attend regular dermatology clinics, to better understand the “real world” use of these medicines. It aims to look at side effects, especially for patients taking medication for other conditions, to increase understanding of the risk of using these therapies. It will also look at the "real cost" of these eczema treatments, to examine how much the therapies cost in the long term compared to how well they work.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Insufficient understanding of the study by the patient and/or parent/guardian.2. Patients who are currently participating in a randomised clinical trial.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Mr
Prakash
Patel
02071887188
A-Star@gstt.nhs.uk
Prof
Carsten
Flohr
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by King's College London; Guy's and St Thomas' NHS Foundation Trust and funded by British Skin Foundation.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 38716
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
